As communities and civil society from the Asia-Pacific region, we ask Member States at this UN High Level Meeting on HIV/AIDS to:
Retain the naming of key populations, including transgender people, consistently throughout all relevant sections in the 2016 Political Declaration, especially in paragraphs that outline strategies and responses.
Commit to a roadmap towards decriminalization of key populations and removing age restrictions and parental and marital consent requirements for adolescents and young people.
Ensure universal access to comprehensive harm reduction, sexual and reproductive health and rights, HIV information services and comprehensive sexuality education for all.
Ensure implementation of prevention and care strategy for women and girls.
Commit to removing policies on HIV-related travel restrictions and deportation.
Establish a robust and systematic assessment of how countries fulfill its human rights obligations, including the right to health, especially for key populations and women and girls.
Commit to establishing funding mechanisms for civil society and critical enablers.
Develop sustainable mechanisms to ensure the availability, affordability and accessibility of treatment and diagnostics for HIV, TB, Hep-C and other co-infections in ALL low and middle-income countries.
Utilize all TRIPS flexibilities to prevent evergreening and other patent rights abuses that curtail access to medicines, diagnostics and vaccines. LDCs should use the TRIPS transition to 2021 and pharmaceuticals transition to 2033 and suspend IP barriers on generic medicines.
Remove TRIPS-plus provisions that negatively impact production of generic medicines; and remove all TRIPS-plus demands from the Regional Comprehensive Economic Partnership Agreement.
Support and promote all efforts at local production of pharmaceuticals.
Provide an enabling environment and policy space for community and civil society to engage meaningfully in all aspects of the AIDS response, beyond just mere project implementer or beneficiaries.